GlassScriptPhysician profile
David B Bodkin
NPI 1295875938
$5,973.57
in general payments reported to CMS, 2019-2025
16 companies · $946 in 2025
The $946 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $909 · 2020: $481 · 2021: $653 · 2022: $1,723 · 2023: $753 · 2024: $509 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929 · Entertainment: $259 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.81 |
| Entertainment | $258.79 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,101.87 | 2019-2025 | Myday Contact Lens |
| Alcon Vision LLC | $1,106.75 | 2020-2025 | Total30, Precision7 |
| Optos, INC. | $276.95 | 2021-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Topcon Healthcare, INC. | $241.26 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $225.00 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $193.93 | 2020-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $179.44 | 2022-2025 | Infuse |
| Lumenis Be INC | $154.73 | 2024 | Optilight |
| Lkc Technologies, INC. | $118.76 | 2025 | |
| Alcon Research LLC | $91.01 | 2019 | |
| Dompe US, INC. | $85.50 | 2024 | Oxervate |
| Allergan, INC. | $71.03 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $69.90 | 2024-2025 | Xdemvy |
| Abbvie INC. | $25.86 | 2022 | |
| Sight Sciences, INC. | $15.82 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bodkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.